On July 22, 2019, the United States Food and Drug Administration (“FDA”) sent a Warning Letter (the “Letter”) to Curaleaf, Inc. notifying the company that FDA considers several products Curaleaf sells on its website, specifically its “CBD Lotion,” “CBD Pain-Relief Patch,” five versions of its “CBD … Read more about Largest U.S. CBD Company Hit with Warning Letter from FDA